Skip to content
10-K

Annual Report

Silo Pharma, Inc. SILO

0001013762-25-004139

← back to feed
Filed
Mar 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 26, 2025 4.48M sh
Shares Diluted FY 2024 · Dec 31, 2023 3.08M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$3.22M
Cash And Equivalents FY 2024 · Dec 31, 2023 $3.52M
Current Liabilities FY 2024 · Dec 31, 2023 $775.59K
Total Liabilities FY 2024 · Dec 31, 2023 $1.57M
Current Assets FY 2024 · Dec 31, 2023 $7.68M
Total Assets FY 2024 · Dec 31, 2023 $7.75M
Eps Diluted FY 2024 · Dec 31, 2023 −$1.20
Eps Basic FY 2024 · Dec 31, 2023 −$1.20
Rd Expense FY 2024 · Dec 31, 2023 $845.09K
Net Income FY 2024 · Dec 31, 2023 −$3.7M
Operating Income FY 2024 · Dec 31, 2023 −$3.86M
Gross Profit FY 2024 · Dec 31, 2023 $66.26K
Cost Of Revenue FY 2024 · Dec 31, 2023 $5.84K
Revenue FY 2024 · Dec 31, 2023 $72.1K
Stockholders Equity FY 2024 · Dec 31, 2022 $10.34M